Therefore, in the present work, we aimed to investigate the role of HO-1 in hypoxia-driven GBM progression by testing the effect of the new synthesized azole-based HO-1 inhibitor VP18/58 on the hypoxia-triggered pathway. The gene discussed is HMOX1; the disease is glioblastoma.